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Abstract 15 
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome causes absence or underdevelopment of 16 
uterus and vagina, but women’s subjective experience remains understudied. This systematic 17 
review was conducted to examine the psychological and health-related quality of life outcomes 18 
of MRKH syndrome. Twenty-two articles identified through electronic search matched the 19 
inclusion criteria and were included in our review. MRKH syndrome may be associated with 20 
psychological symptoms and impaired quality of life, but especially with poor sexual esteem and 21 
genital image. Women may experience difficulties managing intimacy and disclosing to partners. 22 
Mothers are often overprotective and overinvolved, with consequent negative emotions in 23 
women with the disease.   24 
 25 
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Introduction 33 
 34 
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, or Müllerian aplasia, is an important 35 
cause of vaginal agenesis, a congenital condition that affects one in every 5000 female births 36 
(Herlin et al., 2016) and is characterized by the underdevelopment or complete absence of uterus 37 
and vagina, despite the presence of normal secondary sexual characteristics and external 38 
genitalia, a 46,XX karyotype, and functioning ovaries and fallopian tubes (Dabaghi et al., 2019; 39 
Fedele et al., 2010; Fliegner et al., 2014). The disease usually manifests itself during adolescence 40 
with primary amenorrhea and is subsequently diagnosed by ultrasound and magnetic resonance 41 
imaging in most cases (Bombard and Mousa, 2014).  42 
Medical treatment of MRKH syndrome involves the creation of a neovagina using non-43 
surgical and surgical procedures. Non-surgical approaches entail vaginal enlargement with 44 
dilators, using gradual simple pressure with increasingly larger devices (Frank method) (Dabaghi 45 
et al., 2019). When non-surgical methods do not enable sexual intercourse, a variety of surgical 46 
interventions with different techniques can be performed to create a neovagina (Watanabe et al., 47 
2017). All these procedures may have complications such as for example dyspareunia and 48 
urinary tract obstruction (Dabaghi et al., 2019). Overall, women are more likely to prefer 49 
surgical procedures because these interventions are experienced as faster and less frustrating than 50 
non-surgical methods, which can be difficult to practice also due to cultural and social 51 
limitations, with consequent feelings of embarrassment (Dabaghi et al., 2019).   52 
 In a 2009 literature review examining the psychological impact and quality of life (QoL) 53 
outcomes of MRKH syndrome (the latest published review on this topic, at least to our 54 
knowledge), Bean and colleagues (2009) reported that women may be able to physically engage 55 
in penetrative sex after the creation of a neovagina, but having an anatomically intact vagina 56 
does not necessarily lead to optimum sexual function, which also requires good psychological 57 
conditions. The literature examined in the Bean et al. (2009) study provided evidence regarding 58 
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the disruptive impact of the disease on women’s sense of themselves, with poor self-esteem and 59 
body disturbance. In this context, the inability to carry a pregnancy due to uterine absence or 60 
abnormality (a condition referred to as absolute uterine factor infertility; Ejzenberg et al., 2019) 61 
represents an important risk factor associated with feelings of inadequacy deriving from 62 
comparisons with healthy women (Bean et al., 2009; Heller-Boersma et al., 2007).  63 
Given this background, we reviewed the research evidence published in the last decade, 64 
after the Bean et al. (2009) study, to describe the psychological impact of MRKH syndrome, as 65 
well as the effects of the disease on women’s health-related QoL (HRQoL, a multidimensional 66 
concept focused on the specific impact of health—including medical conditions and their 67 
treatment—on people’s lives, in terms of physical, mental, and social functioning; Bourdel et al., 68 
2019). 69 
 70 
Materials and methods 71 
 72 
This review was designed to provide a comprehensive picture of the psychological and HRQoL 73 
conditions of women with MRKH syndrome. Thus, we included quantitative and qualitative 74 
studies reporting original research evidence on this topic. As far as possible for this review, we 75 
followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA; 76 
Moher et al., 2010).  77 
 78 
Electronic search 79 
From June to August 2019 we conducted a systematic electronic search of two databases 80 
(PubMed and PsycINFO). The search process is displayed in Supplemental Figure 1. After 81 
preliminary examination of title, abstract, and keywords of a sample of articles focused on the 82 
topic of interest, we identified the following set of search terms that were combined using 83 
appropriate Boolean operators (AND / OR): “Mayer-Rokitansky-Küster-Hauser syndrome”, 84 
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“vaginal agenesis”, Rokitansky, psychological, anxiety, depression, coping, personality, “lived 85 
experience”, neuroticism, “quality of life”, distress, vaginoplasty, sigmoid, dilator, Vecchietti, 86 
Davydov, McIndoe, Frank. The reference lists of the studies included in this review were also 87 
examined to identify other eligible studies.   88 
 89 
Article selection 90 
We included articles written in English and reporting psychological and HRQoL outcomes of the 91 
disease and/or its treatment. Given that Bean et al. (2009) considered studies published between 92 
1955 and 2007, we included articles published from January 2008 to August 2019. We excluded 93 
literature reviews, commentaries, case reports, doctoral theses, and opinion papers. Due to the 94 
psychological focus of our research question, we did not include studies reporting exclusively 95 
sexological outcomes (i.e., vaginal length, sexual function, sexual distress, and sexual 96 
satisfaction) of MRKH treatments (a systematic review of this body of literature was recently 97 
conducted by Dabaghi et al., 2019). However, we included studies that explored the association 98 
between sexological outcomes and psychological factors, such as for instance women’s feelings 99 
and emotions, self-esteem and body image. We excluded studies that reported psychological and 100 
HRQoL outcomes of MRKH and other genital anomalies without discriminating between 101 
malformation types. After duplicates elimination, articles were screened independently by the 102 
first three authors, starting with titles and abstracts, and subsequently retrieving full texts.  103 
 104 
Data extraction and quality assessment 105 
Data extraction involved the creation of an Excel recording spreadsheet to summarize 106 
information of interest (i.e., authors, date and country of publication, research aims, sample 107 
description, study design and methods, main results). The first three authors independently 108 
assessed and subsequently discussed the quality of all eligible studies following seven criteria 109 
applicable to both quantitative and qualitative studies (Culley et al., 2013; Shepherd et al., 2006): 110 
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(1) presence of a comprehensive theoretical framework; (2) clear explanation of research aims; 111 
(3) appropriate description of factors important for result interpretation; (4) precise sample 112 
description; (5) detailed presentation of materials and methods; (6) data analysis performed by 113 
more than one researcher; (7) rigorous (vs. speculative) interpretation of results based on the 114 
original research evidence provided in the study. The included studies had to meet at least four 115 
of these seven criteria (Canzi et al., 2019). All discrepancies among authors were discussed until 116 
consensus was reached.  117 
 118 
Analysis and narrative synthesis  119 
The analytic process entailed a three-step thematic analysis (Dixon-Woods et al., 2005) that 120 
involved (1) reading all articles to identify relevant issues, (2) categorizing these issues to define 121 
the prominent themes, and (3) providing a narrative synthesis of the findings. A narrative 122 
approach—rather than standard systematic review methodology—is particularly appropriate to 123 
summarize findings from very different types of studies, such as those included in this review 124 
(Culley et al., 2013). 125 
 126 
Results 127 
 128 
Selection and characteristics of the studies 129 
A total of 185 articles were initially retrieved from electronic search (Supplemental Figure 1). At 130 
the end of the selection process, 22 research articles were included in our review. No further 131 
material was identified after reference lists examination. Characteristics and main findings of the 132 
included articles are summarized in Table 1. Of these 22 studies, 16 (73%) were quantitative, 2 133 
(9%) were qualitative, and 4 (18%) used a mixed-methods design. Six studies (27%) focused on 134 
the outcomes of specific treatments, mainly surgical procedures (Carrard et al., 2012; 135 
Cheikhelard et al., 2018; Gatti et al., 2010; Labus et al., 2011; Leithner et al., 2015; Sabatucci et 136 
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al., 2018). Most of these studies examined not only sexual function, but also women’s body 137 
image and genital perception, sense of femininity, self-esteem, as well as psychological 138 
symptoms and QoL. The other 16 studies (73%) were primarily focused on women’s subjective 139 
reaction to the disease, including coping styles, psychological and sexual health, impact of 140 
diagnosis, infertility and attitudes toward motherhood.  141 
Almost all studies (86%) originated in Europe, especially in the UK, Germany, and 142 
Poland. Two studies were conducted out of Europe, specifically in North America (Ernst et al., 143 
2014) and Australia (Kimberly et al., 2011), and one study involved both Italy and Bangladesh 144 
(Gatti et al., 2010). Only one study reported longitudinal findings (Sabatucci et al., 2018). Two 145 
articles (Ernst et al., 2014; Patterson et al., 2014) described findings from qualitative studies 146 
providing an in-depth exploration of women’s lived experience of MRKH syndrome, while the 147 
remaining 19 articles (86%) reported cross-sectional results.  148 
The number of MRKH patients included in the studies ranged from 5 to 131 (total N = 149 
1017), and the median number was 46. Age at diagnosis ranged from 13 to 21 years and time 150 
since diagnosis ranged from 1 to 39 years. In 7 studies (32%), women with MRKH were 151 
exclusively compared with healthy controls (Bargiel-Matusiewicz et al., 2015; Beisert et al., 152 
2015; Gatti et al., 2010; Heller-Boersma et al., 2009; Leithner et al., 2015; Pastor et al., 2016; 153 
Weijenborg et al., 2019). In 6 studies (27%), comparisons were made with women with complete 154 
androgen insensitivity syndrome (CAIS) and/or polycystic ovarian syndrome (PCOS) (Brunner 155 
et al., 2015; Dear et al., 2019; Fliegner et al., 2014, 2018; Krupp et al., 2012; Laggari et al., 156 
2009). In 4 studies (18%), MRKH patients were exclusively compared with general or 157 
standardization population (Cheikhelard et al., 2018; Kimberly et al., 2011; Liao et al., 2011; 158 
Sabatucci et al., 2018).  159 
Various questionnaires (either standardized or non-standardized and researcher-made) 160 
were used to measure MRKH psychological and HRQoL outcomes. The Beck Depression 161 
Inventory (BDI) and the Brief Symptom Inventory (BSI) were the most used scales to assess 162 
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psychological symptoms (Fliegner et al., 2014, 2018; Gatti et al., 2010; Krupp et al., 2012; 163 
Labus et al., 2011; Laggari et al., 2009), while HRQoL was mostly evaluated using the World 164 
Health Organization Quality of Life - Brief version (WHOQoL-BREF) (Cheikhelard et al., 2018; 165 
Kimberly et al., 2011; Leithner et al., 2015).       166 
 167 
Narrative synthesis 168 
The thematic analysis conducted led to the identification of 8 prominent themes: (1) reactions to 169 
diagnosis and coping styles; (2) psychological symptoms; (3) body image; (4) self-esteem and 170 
female identity; (5) infertility and attitudes toward motherhood; (6) sexuality and intimate 171 
relationships; (7) family and social relationships; (8) HRQoL. 172 
 173 
Reactions to diagnosis and coping styles. Four studies (18%) reported information regarding 174 
women’s reactions to diagnosis and coping styles (Bargiel-Matusiewicz et al., 2013, 2015; 175 
Kimberly et al., 2011; Patterson et al., 2014). Women’s reactions to diagnosis are commonly 176 
characterized by negative emotions, or even suicidal thoughts in a minority of cases (Kimberly et 177 
al., 2011). Being diagnosed with MRKH syndrome entails dealing with increased sense of 178 
difference compared with peers (Patterson et al., 2014). Therefore, young women with the 179 
disease may try to minimize or even avoid exposure to stressful situations that involve social 180 
comparisons (e.g., being around pregnant women) (Patterson et al., 2014). In the study by 181 
Patterson et al. (2014), women also tried to avoid thinking about MRKH by focusing for instance 182 
on their careers and plans for the future. As demonstrated by Bargiel-Matusiewicz et al. (2013, 183 
2015), women’s emotional state may also be influenced by their personality, especially by 184 
neuroticism, which enhances negative emotions such as uncertainty, disappointment, anger, and 185 
depression. The authors also showed that women who had been aware of their condition for 186 
more than 6 years reported higher levels of neuroticism and lower problem-focused strategies 187 
compared with healthy controls (Bargiel-Matusiewicz et al., 2015). Women with MRKH seemed 188 
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more likely to use emotion-focused strategies that led them, combined with neuroticism, to be 189 
excessively focused on negative emotions (Bargiel-Matusiewicz et al., 2013, 2015).   190 
 191 
Psychological symptoms. Evidence regarding the presence of psychological symptoms (such as 192 
for instance anxiety, depression, eating disorders, psychoticism) was provided by 11 studies 193 
(50%), of which 7 reported information about the psychological health of MRKH patients 194 
regardless of medical treatment (Fliegner et al., 2014, 2018; Heller-Boersma et al., 2009; Krupp 195 
et al., 2012; Laggari et al., 2009; Liao et al., 2011; Weijenborg et al., 2019), whereas the other 4 196 
focused on the outcomes of specific types of surgical interventions (Carrard et al., 2012; Gatti et 197 
al., 2010; Labus et al., 2011; Leithner et al., 2015). The first subgroup of articles reported 198 
conflicting findings. Three studies indicated that MRKH patients may display high rates of 199 
depression (Fliegner et al., 2014, 2018; Laggari et al., 2009). In the study by Fliegner et al. 200 
(2014), the rates of depression were three times higher than expected, and clinically significant 201 
depression was reported by 29% of patients (Fliegner et al., 2018) and 40% of patients (Laggari 202 
et al., 2009), respectively. There is also evidence that MRKH patients may be more likely to be 203 
affected by anxiety, psychoticism, and eating disorder symptoms than healthy women (Heller-204 
Boersma et al., 2009; Laggari et al., 2009), with 54% of patients displaying high psychological 205 
distress (Krupp et al., 2012). However, in a recent study (Weijenborg et al., 2019), the presence 206 
of psychological symptoms in 54 MRKH patients and 79 healthy controls was assessed using the 207 
Symptom Check-List-90 (SCL-90) and the Hospital Anxiety and Depression Scale (HADS), 208 
with no significant differences between groups. The findings reported by the second subgroup of 209 
studies focused on treatment outcomes indicated that overall women showed good psychological 210 
health after surgery, with no remarkable difference compared to women who used dilators 211 
(Carrard et al., 2012). In two of these studies, women who underwent surgical creation of a 212 
neovagina did not report higher rates of psychological symptoms (including depression) than 213 
healthy controls (Gatti et al., 2010; Leithner et al., 2015). Labus et al. (2011) observed that 78% 214 
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of patients who underwent rectosigmoid vaginoplasty did not have depressive symptoms. In the 215 
Carrard et al. (2012) study, 28% of women reported signs of depression, despite increased sexual 216 
function. 217 
 218 
Body image. Evidence regarding body image, including subjective genital perception, was 219 
reported in 5 studies (23%) (Carrard et al., 2012; Dear et al., 2019; Leithner et al., 2015; Pastor 220 
et al., 2017; Weijenborg et al., 2019). The worst outcomes were found when body image was 221 
assessed in terms of vaginal image and perceptions, for instance using the Female Genital Self-222 
Image Scale (FGSIS) (Pastor et al., 2017; Weijenborg et al., 2019). It was observed that MRKH 223 
patients tend to negatively perceive their vagina (e.g., too small, or needing an increase in size) 224 
before (Dear et al., 2019) and after treatment, with poor satisfaction (Pastor et al., 2017). In the 225 
Leithner et al. (2015) study, body image was assessed from a broader perspective, i.e., not 226 
specifically focused on female genitals, with no significant differences between the MRKH 227 
group and healthy controls. In the Carrard et al. (2012) study, body image was generally assessed 228 
in terms of “body image perception” (positive, neither positive nor negative, negative) by means 229 
of a questionnaire developed by the researchers, and changes in body image since treatment were 230 
evaluated. In both studies, MRKH women reported positive outcomes, without differences 231 
related to treatment (sigmoid vaginoplasty vs. Frank method) (Carrard et al., 2012) and 232 
compared with healthy controls (Leithner et al., 2015).  233 
 234 
Self-esteem and female identity. In 4 studies (18%) (Fliegner et al., 2014; Gatti et al., 2010; 235 
Heller-Boersma et al. 2009; Weijenborg et al 2019), self-esteem was assessed using the 236 
Rosenberg Self-Eteem Scale (RSES). In 3 of these studies (Fliegner et al., 2014; Gatti et al., 237 
2010; Weijenborg et al 2019), women with the disease did not report impaired self-esteem. 238 
However, Heller-Boersma et al. (2009) found poorer self-esteem in the MRKH group compared 239 
with healthy controls. Four studies (Brunner et al., 2015; Carrard et al., 2012; Labus et al. 2011; 240 
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Patterson et al. 2014) provided information regarding female identity and sense of femininity. 241 
Gender self-perception was investigated by Brunner et al. (2015), who observed that the majority 242 
of MRKH participants reported having a female gender with heterosexual orientation. Two 243 
studies (Carrard et al., 2012; Labus et al., 2011) reported satisfactory femininity in women who 244 
underwent rectosigmoid vaginoplasty (Labus et al., 2011) and sigmoid vaginoplasty or dilation 245 
(Carrard et al., 2012). On the other hand, in a qualitative study by Patterson et al. (2014) women 246 
described MRKH as a threat to their femininity, describing feelings of inadequacy, an overall 247 
loss of self confidence after diagnosis, and worries about the fact that others may detect their 248 
condition without being told. 249 
 250 
Infertility and attitudes towards motherhood. Four studies (Brunner et al., 2015; Fliegner et al., 251 
2018; Kimberly et al., 2011; Patterson et al., 2014) examined the role of infertility in women 252 
with MRKH. In the Kimberly et al. (2011) study, 79% of participants reported that the reason for 253 
their distress was infertility. Fliegner et al. (2018) observed that MRKH patients showed greater 254 
distress regarding infertility, as well as thoughts and feelings of sadness compared with CAIS 255 
participants. In another study by Brunner et al. (2015), infertility seemed to play an ambiguous 256 
role: for some women, it represented the major source of distress, whereas other women 257 
contradicted this. Attitudes toward motherhood were systematically explored by Fliegner et al. 258 
(2018), who reported that the more positively women saw children, the greater their depression.  259 
As regards reproductive options, the percentage of women who were interested in surrogacy 260 
ranged from 36% (Pastor et al., 2017) to 82% (Carrard et al., 2018). In the Pastor et al. (2017) 261 
study, 91% of women would consider uterus transplantation.    262 
 263 
Sexuality and intimate relationships. The percentage of MRKH participants who had a partner 264 
ranged from 37% (Bargiel et al., 2015) to 76% (Brunner et al., 2015). These percentages are 265 
consistent with findings from other studies included in this review, indicating that women tend to 266 
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have sex before any treatment, although mostly non-penetrative sex (Dear et al., 2019). As 267 
reported by Beisert et al. (2015), although the age of initiation of autoerotic activity can be 268 
similar in women with MRKH compared with healthy women, attempted vaginal intercourse is 269 
less frequent and dyadic sexual activity tends to start later among women with the disease. In a 270 
study by Fliegner et al. (2014), the MRKH group reported pronounced feelings of inadequacy in 271 
sexual situations compared with controls, which were strongly associated with impaired sexual 272 
function. Moreover, women who were not sexually active had higher feelings of inadequacy in 273 
social and sexual situations, and poorer self-esteem. Poor sexual esteem was also observed by 274 
Liao et al. (2011) and Weijenborg et al. (2019), although in the latter and most recent study this 275 
psychological factor was strongly associated with sexual dysfunction and sexual distress, while 276 
Liao et al. (2011) did not find significant correlations between these factors. In the Weijenborg et 277 
al. study (2019), impaired sexual function was also associated with anxiety and global self-278 
esteem. Managing intimacy represented an important difficulty for the women interviewed by 279 
Patterson et al. (2014). Indeed, disclosure was an important issue, as also underlined by Ernst et 280 
al. (2014). Trust and closeness were described as an important motivation for disclosing the 281 
diagnosis, but at the same time women may prefer to wait for being more invested in the 282 
relationship before discussing their condition (Ernst et al., 2014; Patterson et al., 2014). Fear of 283 
rejection (especially due to inability to conceive) was identified as an important deterrent to 284 
disclosure in both qualitative studies. The fact that the partner may find out their condition 285 
represents a source of stress for women (Patterson et al., 2014). However, Pastor et al. (2017), 286 
who examined partners’ perspective using structured interviews, reported that 97% of men at 287 
first did not recognize the artificial vagina and 83% of male partners stated that they did not 288 
consider infertility as a reason for relationship breakup.  289 
 290 
Family and social relationships. Information regarding women’s relationship with their mother 291 
was reported in two articles (Leithner et al., 2015; Patterson et al., 2014). In both studies, 292 
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mothers were described as particularly caring or even overinvolved. As reported in the 293 
qualitative study by Patterson et al. (2014), women experience their diagnosis as personal and 294 
hindering independence may be an issue when mothers are too intrusive (for instance, they take 295 
the lead in consultations with professionals) or overprotective. In another study by Labus et al. 296 
(2011), family was described as the main source of support by women who underwent 297 
rectosigmoid vaginoplasty. Disclosure to friends occurs when women feel comfortable in a 298 
relationship based on trust and sharing secrets, and negative feelings and outcomes related to 299 
disclosing the diagnosis are less frequent with friends than with partners (Ernst et al., 2014). In a 300 
study by Krupp et al. (2012), 90% of MRKH participants who had contacts with other affected 301 
persons considered it beneficial, and 53% of those who did not report any contact wished for 302 
such an experience. MRKH participants who did not want any contact were afraid of 303 
experiencing distress due to an excessive focus on negative topics during the discussion.  304 
 305 
HRQoL. HRQoL was systematically evaluated in 5 studies (23%) using well-known 306 
standardized measures, and specifically the WHRQoL-BREF (Cheikhelard et al., 2018; 307 
Kimberly et al., 2011; Leithner et al., 2015), the Short Form-12 Health Survey (SF-12) (Liao et 308 
al., 2011) and the Psychological General Well Being Index (PGWBI) (Sabatucci et al., 2018). 309 
Except for the Liao et al. (2011) study, the other articles mostly reported treatment outcomes. 310 
Overall, women showed improved HRQoL after treatment as compared with their pre-treatment 311 
situation (Sabatucci et al., 2018), healthy controls (Leithner et al., 2015), and the general 312 
population (Kimberly et al., 2011). In the Cheikhelard et al. (2018) study, there were no 313 
significant differences in HRQoL between the surgery group and the dilation only group, 314 
although women reported poorer psychosocial functioning compared with the general 315 
population. In another study (Liao et al., 2011), women showed good physical QoL, but lower 316 
scores on the mental component of the SF-12 compared with a standardization population. 317 
  318 
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Discussion 319 
This systematic review aimed at providing a comprehensive description of the psychological 320 
impact and HRQoL outcomes of MRKH syndrome by summarizing the research evidence 321 
published in the last decade. Through systematic electronic search, we identified 22 articles that 322 
matched our inclusion criteria and were included in this review. Thematic analysis was 323 
conducted and a narrative synthesis of the findings was provided.  324 
The studies included in our review confirmed that MRKH diagnosis represents a stressful 325 
event, with negative emotional reactions characterized by increased sensitivity to difference and 326 
impaired sense of femininity, especially due to infertility (Kimberly et al., 2011; Patterson et al., 327 
2014). The psychological burden of the disease was highlighted in several studies (e.g., Heller-328 
Boersma et al., 2009), with women affected by MRKH displaying anxiety and depression, 329 
psychoticism, and even eating disorder symptoms, and poor self-esteem, but more recent articles 330 
reported contradicting findings (Weijenborg et al., 2019) and showed overall good QoL, 331 
especially after treatment (Sabatucci et al., 2018). Such discrepancies may be partly explained by 332 
the fact that women’s psychological reactions to the disease may be shaped by individual 333 
characteristics such as personality traits (Bargiel-Matusiewicz et al. 2013, 2015), as well as by 334 
psychological adjustment before the diagnosis (Bean et al., 2009).  335 
Besides confirming the findings of previous studies (Bean et al., 2009), our review adds 336 
to the extant literature by identifying other sources of psychological vulnerability in women with 337 
MRKH syndrome. First, women’s genital image (rather than general body image) is often 338 
negative, indicating that women are not satisfied with their vagina, to the point of feeling 339 
embarrassed and uncomfortable during sexual contacts, with concerns about their genital 340 
function (Pastor et al., 2017). These beliefs may have a negative impact on women’s sexual 341 
esteem, which tends to be poor in women with MRKH and thus leads to sexual dysfunction 342 
(Weijenborg et al., 2019), as well as to feelings of inadequacy and fear of being rejected or 343 
considered “a freak” (Patterson et al., 2014). Second, women are worried that their partner may 344 
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detect their condition without being told, but this belief is not supported by research evidence, 345 
which suggests that most men are not able to distinguish the neo-created from the natural vagina 346 
(Pastor et al., 2017). Third, the quality of mother-daughter relationship also deserves attention, 347 
because mothers may be perceived as excessively involved and intrusive, for instance during 348 
treatment (Patterson et al., 2014). 349 
 350 
Limitations 351 
Due to the broad nature of our research question, as well as to the paucity of psychological 352 
articles in the context of MRKH syndrome, we included studies with different objectives and 353 
methodologies. The methodological variability across studies, in terms of research designs, 354 
measures (i.e., standardized scales and researcher-made questionnaires), and assessment times 355 
(time since diagnosis ranged from 1 to 39 years), may account for some of the discrepancies in 356 
the findings, especially as regards psychological symptoms. Because systematic comparisons 357 
between studies were not possible, we could not describe women’s psychological health 358 
trajectories during the years following diagnosis and treatment (e.g., short- vs. long-term 359 
effects).  360 
  361 
Suggestions for future research and clinical practice     362 
Future studies should investigate women’s pathways through MRKH syndrome in a more 363 
systematic fashion, for instance by exploring the association between time since diagnosis and 364 
onset of psychological symptoms. This would allow timely implementation and personalization 365 
of multidisciplinary treatment. Longitudinal research is encouraged, considering that only one of 366 
the included studies had an actual longitudinal design (Sabatucci et al., 2018).  367 
Patients’ subjective experience of dilators requires further exploration and qualitative 368 
research may be particularly useful to explore sociocultural and psychological implications of 369 
this type of treatment, as well as the role of family. In this regard, MRKH patients are often 370 
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adolescents and come to the visits with their parents, who also experience emotional distress. 371 
Psychological counseling may help parents and especially mothers, who are sometimes 372 
perceived by patients as intrusive and overinvolved (Patterson et al., 2014), improve the quality 373 
of the support provided to their daughter.  374 
MRKH syndrome is complex and a biopsychosocial perspective should always guide 375 
research and multidisciplinary treatment. The creation of a neovagina, either with or without 376 
surgery, may contribute to decrease women’s concerns about their vagina and thus reduce 377 
feelings of difference, especially when properly managed by a multidisciplinary team (Leithner 378 
et al., 2015). However, the creation of the neovagina itself, although not associated with negative 379 
psychological and HRQoL outcomes, is not able to provide a definitive relief to women with 380 
MRKH syndrome, who experience multiple sources of distress. Therefore, psychological 381 
counseling should be routinely offered to these patients, with assessment of women’s beliefs 382 
regarding their genitals and partner’s perceptions. The issue of disclosure, especially to intimate 383 
partners, should also be addressed and discussed. Reproductive options should be clearly 384 
explained to patients, as well as the specific type of infertility related to MRKH syndrome. In 385 
fact, these women are not able to carry a pregnancy due to uterine absence or abnormality, but 386 
they may have normally functioning ovaries.  387 
The language used by professionals is fundamental in the context of MRKH syndrome 388 
(Bean et al., 2009), as well as good doctor-patient communication, especially when working with 389 
young adolescents who are building their identity. Psychologists may help physicians manage 390 
the complexity of the disease and improve the quality of their relationship with patients and their 391 
families.  392 
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Table 1. Characteristics of the studies included in the systematic review 
Authors, year of 
publication, 
country of 
analysis 
Study aim/research 
question 
MRKH 
(n) 
Non-
MRKH (n)  
 
Evaluation of 
psychological 
and HRQoL 
outcomes 
MRKH 
Treatment  
 
Relevant findings 
 
Bargiel-
Matusiewicz et al, 
2013 (Poland) 
 
To examine the 
associations between 
neuroticism, coping styles, 
and positive/negative 
emotions, and the 
underlying mechanisms, in 
women with MRKH 
syndrome  
 
46 
 
— 
 
Quantitative. 
NEO-FFI; CISS; 
Emotional State 
Survey 
 
— 
 
Emotional coping style mediated the 
relation between neuroticism and affects. 
Time of awareness of MRKH moderated the 
association between neuroticism and 
negative affects 
Bargiel-
Matusiewicz et al, 
2015 (Poland) 
To compare personality 
traits and coping styles in 
women with MRKH vs. 
healthy controls 
46 44 healthy  Quantitative. 
NEO-FFI; CISS  
— Higher neuroticism, greater emotion-
focused coping and lower problem-focused 
coping in the MRKH group  
Beisert et al, 2015 
(Poland) 
To examine sexual activity 
in MRKH patients vs. 
healthy controls 
31 31 healthy  Quantitative. 
Psychosexual 
biography 
Surgery (n=21) No significant differences regarding age at 
initiation of autoerotic and anal activity, and 
level of sexual arousal. In MRKH 
participants, less frequent vaginal and oral 
intercourse, later initiation of dyadic sexual 
activity, less frequent orgasm during 
intercourse    
Brunner et al, 
2015 (Germany) 
To examine gender self-
perception in women with 
CAIS vs. subfertile or 
infertile women with 
MRKH and PCOS 
49 11 with 
CAIS; 55 
with PCOS 
Mixed-methods. 
Multidimensional 
questionnaire 
— The majority of MRKH participants did not 
report decreased female identity or doubts 
about female role  
 23 
Carrard et al, 2012 
(France) 
To evaluate functional and 
psychosexual outcomes of 
sigmoid vaginoplasty  
59 — Quantitative. 
Questions 
assessing 
depression, body 
image, desire of 
motherhood 
Sigmoid 
vaginoplasty 
(n=48); Frank’s 
method (n=11) 
Overall, 28% of women reported signs of 
depression, despite increased sexual 
function after treatment. No significant 
group differences in psychological 
outcomes  
Cheikhelard et al, 
2018 (France) 
To compare dilation and 
surgery as regards QoL 
outcomes, anatomical 
results, and complications  
131 — Quantitative. 
WHOQoL-BREF 
 
Dilation only 
(n=26); Surgery 
(Sigmoid 
vaginoplasty, 
Davydov, 
Dupuytren, 
Vecchietti, 
McIndoe) (n=84) 
No significant differences in global quality 
of life across the two groups. Overall, lower 
psychosocial health and social relationship 
scores compared with the general 
population 
Dear et al, 2019 
(UK) 
To examine pretreatment 
sexual experience in 
women with vaginal 
agenesis  
115 22 with 
CAIS 
Quantitative. 
Sexual 
Experiences 
Questionnaire; 
MSQ; Vaginal 
Self-Perceptions  
— The majority of women with MRKH 
syndrome reported sexual activity before 
treatment (mostly non-penetrative sex). 
Most women perceived their vagina as too 
small. No significant group differences 
Ernst et al, 2014 
(USA) 
To investigate the process 
and the emotional impact 
of disclosing MRKH 
diagnosis to peers during 
adolescence and young 
adulthood 
9 — Qualitative. 
Semistructured 
telephone 
interviews 
— Motivations for disclosing were trust and 
closeness, honesty and responsibility 
towards partner. Deterrents were fear of 
rejection, or being misunderstood or 
considered a “freak”, lack of trust and 
comfort, and infertility. 
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Fliegner et al, 
2014 (Germany) 
To examine psychological 
and sexual wellbeing in 
women with CAIS vs. 
MRKH and the association 
between psychological 
factors and sexual function 
49 11 with 
CAIS 
Mixed-methods. 
FUSS; RSES; BSI 
(only depression 
subscale); open 
question  
Dilation only 
(n=2); surgery 
(n=42) 
In MRKH patients, feelings of inadequacy 
in sexual situations affected sexual function. 
High rates of depression (as for CAIS). 
Overall satisfaction with sexual life. Sexual 
problems related to issues regarding vaginal 
functioning. Worse psychological outcomes 
in non-sexually active patients   
Fliegner et al, 
2018 (Germany) 
 
To explore the role of 
infertility and attitudes 
towards motherhood in 
women with CAIS and 
MRKH syndrome 
 
49 12 with 
CAIS 
Quantitative. 
Self-developed 
questionnaire; 
FEMu; BSI 
— In MRKH women, moderate wish for a 
child, with greater distress, thoughts, and 
sadness regarding infertility; 29% showed 
clinically significant depression; positive 
attitudes towards motherhood associated 
with depression 
Gatti et al, 2010 
(Italy and 
Bangladesh) 
 
To investigate the 
psychological and 
psychosexual experience 
of MRKH patients who 
underwent total sigmoid 
vaginal replacement 
43 30 healthy  Quantitative. 
RSES; BDI; 
CTLMA 
Total sigmoid 
vaginal 
replacement  
No significant differences in psychological 
function between MRKH patients and 
controls 
Heller-Boersma et 
al, 2009 (UK) 
To compare the 
psychological conditions 
of women with MRKH vs. 
healthy women; to 
examine whether the 
psychological impact of 
MRKH decreases over 
time 
66 31 healthy  Quantitative. 
SCL-90-R; RSES; 
IIP-32; EDI 
— In MRKH patients, higher phobic anxiety 
and psychoticism; lower self-esteem; 
greater eating disorders symptoms. No 
significant correlations with time from 
diagnosis 
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Kimberly et al, 
2011 (Australia) 
To evaluate long-term 
quality of life and sexual 
function outcomes in 
women treated for vaginal 
agenesis 
28 — Quantitative.  
WHOQoL-BREF; 
Questionnaire 
assessing 
reactions to 
diagnosis  
Sheare’s or 
McIndoe 
procedure (n=4); 
dilators (n=16) 
No significant differences in overall quality 
of life relative to Australian general 
population; negative feelings after 
diagnosis, mostly related to infertility  
Krupp et al, 2012 
(Germany) 
To investigate how women 
with CAIS, MRKH, or 
PCOS experience contact 
with other affected 
individuals 
49 11 with 
CAIS; 55 
with PCOS 
Mixed-methods. 
Questionnaire 
developed to 
examine different 
aspects of the 
contact 
experience; BSI 
— Among MRKH patients, 62% had contacts 
with other affected women; of these, 90% 
considered contact beneficial; 53% wished 
to have such contact. High levels of distress 
in 54% of MRKH women 
Labus et al, 2011 
(Serbia) 
To evaluate sexual and 
psychosocial adjustment 
after rectosigmoid 
vaginoplasty 
36 — Quantitative. 
BDI; 
Questionnaire 
assessing 
postoperative 
satisfaction, social 
and sexual 
adjustment 
Rectosigmoid 
vaginoplasty 
79% of patients did not report depression. 
Most participants were satisfied with 
surgery, considered as the best treatment 
option; 94% reported satisfactory femininity 
with heterosexual orientation. Family was 
the main source of support  
Laggari et al, 
2009 (Greece) 
 
To investigate anxiety and 
depression in women with 
MRKH and PCOS 
5 22 with 
PCOS; 22 
healthy 
Quantitative. 
BDI; STAI; 
Stressful Life 
Events Schedule 
— 40% of MRKH patients reported clinical 
depression and were more likely to report 
anxiety and depression than healthy women  
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Leithner et al, 
2015 (Austria) 
To examine sexual and 
psychosocial functioning 
in women with MRKH 
after surgical creation of a 
neovagina 
 
10 20 healthy Quantitative. 
PHQ; BSI;  
WHOQoL-BREF; 
FBeK; PBI 
 
Wharton-
Sheares.George 
technique  
No significant group differences in 
depressive symptomatology, psychosocial 
burden, QoL and body image. Less 
psychological impairment in MRKH 
patients. Closer mother-daughter 
relationship     
Liao et al, 2011 
(UK) 
To explore QoL, 
psychological health, and 
sexuality in MRKH 
patients 
56 — Quantitative. 
SF-12; HADS; 
MSQ 
Dilator only 
(n=36); Surgery 
(n=8) 
Compared with a standardization sample, 
MRKH patients reported greater physical 
QoL, but poorer scores on the mental QoL 
component and greater anxiety. No 
differences for depression. Poor sexuality 
(especially sexual esteem) 
Pastor et al, 2017 
(Czech Republic) 
To investigate sexual 
wellbeing and partners’ 
perspective among MRKH 
patients with a neovagina 
42 45 healthy; 
patients’ 
sexual 
partners 
Mixed-methods. 
FGSIS; 
semistructured 
and structured 
interviews 
Laparoscopic 
Vecchietti 
vaginoplasty 
MRKH patients reported poorer genital 
image than healthy controls. 97% of men at 
first did not recognize the artificial vagina. 
Infertility was not considered a reason for 
relationship breakup by 83% of men 
Patterson et al, 
2014 (UK) 
 
To investigate young 
women’s subjective 
experience of MRKH 
syndrome 
5 — Qualitative. 
Semistructured 
interview 
 
— Although the diagnosis was considered as a 
private experience, mothers were heavily 
involved. Women reported sensitivity to 
difference and intimacy problems. Female 
identity and self-esteem were compromised 
by the disease  
Sabatucci et al, 
2018 (Italy) 
To evaluate long-term 
sexual function and QoL 
after vaginoplasty  
39 — Quantitative. 
PGWBI 
Modified Abbé-
McIndoe 
technique using 
autologous in 
vitro cultured 
vaginal tissue   
Patients reported greater QoL compared 
with their pre-intervention condition as well 
as with the median standardized profile of 
the general population 
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Weijenborg et al, 
2019 (The 
Netherlands) 
 
To examine sexual and 
psychological wellbeing in 
MRKH patients  
 
54  
 
79 healthy 
 
Quantitative. 
SES; FGSIS; 
SCL-90; HADS; 
RSES; MMQ 
(subscale 
relationship 
satisfaction); 
Sexual and 
Physical Abuse 
Questionnaire 
(three questions) 
 
Vecchietti (n=1); 
Davydov (n=5); 
McIndoe (n=5); 
Williams (n=1); 
cutaneous groin 
flaps (n=1); 
unspecified (n=2)  
 
MRKH patients reported longer 
relationships, less frequent abuse 
experiences, poorer sexual esteem and 
genital image, but similar psychological 
health condition compared with controls. 
Psychological factors (especially sexual 
esteem) predicted sexual dysfunction 
 
Abbreviations: BDI (Beck Depression Inventory); BSI (Brief Symptom Inventory); CAIS (Complete Androgen Insensitivity Syndrome); CISS (Coping 
Inventory for Stressful Situations); CTMLA (Cohen Test for Life Management Ability); EDI (Eating Disorder Inventory); FEMu (Questionnaire on Attitudes 
toward Motherhood); FGSIS (Female Genital Self-Image Scale); FUSS (Feelings of Inadequacy in Social and Sexual Situations); HADS (Hospital Anxiety and 
Depression Scale); IIP-32 (Inventory of Interpersonal Problems); MMQ (Maudsley Marital Questionnaire); MSQ (Multidimensional Sexuality Questionnaire); 
NEO-FFI (NEO Five Factor Inventory); PBI (Parental Bonding Instrument); PCOS (Polycystic Ovary Syndrome); PGWBI (Psychological General Well Being 
Index); PHQ (Patient Health Questionnaire); RSES (Rosenberg Self-Esteem Scale); SCL-90 (Symptom Check-List); SES (Sexual Esteem Subscale of the MSQ); 
SF-12 (Short Form-12 Health Survey); STAI (State-Trait Anxiety Inventory);  WHOQoL-BREF (World Health Organization Quality of Life - Brief version) 
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